Agendia®, Inc., announced today that new data on its early-stage breast cancer genomic tests and their ability to inform treatment selection decisions will be presented at the San Antonio Breast ...

His faculty adviser, Wyatt Cross, believes that’s one reason Conti was awarded a prestigious National Science Foundation ...